Epilepsy Cases in Pregnant and Postpartum Women: A Practical Approach

ABSTRACT

Approximately one million women with epilepsy in the United States are in their active reproductive years. Many women with epilepsy require treatment during pregnancy, and many antiepileptic drugs (AEDs) are potential teratogens. Unfortunately, many pregnancies are often not identified until after organ formation has occurred. However, most women with epilepsy will have a normal pregnancy and a favorable outcome. Effective control of maternal seizures with the least risk to the fetus is ideal, but maternal and fetal risks are still likely increased over the general population. In 2009, the American Academy of Neurology (AAN) and the American Epilepsy Society (AES) published Practice Parameter Updates on the pregnant woman with epilepsy.[1] [2] [3] These guidelines reviewed medications, teratogenicity, obstetric outcomes, vitamins, breastfeeding, and other management issues in the pregnant woman with epilepsy. Through a case-based approach, these guidelines will be reviewed, and approaches to diagnosis and management of the pregnant woman with epilepsy will be discussed.

KEYWORDS

Epilepsy - pregnancy - postpartum - women - management

REFERENCES

• 1 Harden C L, Hopp J, Ting T Y American Academy of Neurology et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.  Neurology. 2009;  73 (2) 126-132
• 2 Harden C L, Meador K J, Pennell P B American Academy of Neurology et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.  Neurology. 2009;  73 (2) 133-141
• 3 Harden C L, Pennell P B, Koppel B S American Academy of Neurology et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.  Neurology. 2009;  73 (2) 142-149
• 4 Hoyert D L, Mathews T J, Menacker F et al.. Annual summary of vital statistics: 2004.  Pediatrics. 2006;  117 168-183
• 5 Cunnington M C, Weil J G, Messenheimer J A, Ferber S, Yerby M, Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry.  Neurology. 2011;  76 (21) 1817-1823
• 6 Tomson T, Battino D. Teratogenic effects of antiepileptic medications.  Neurol Clin. 2009;  27 (4) 993-1002
• 7 Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists . ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996.  Int J Gynaecol Obstet. 1997;  56 (3) 279-286
• 8 De Wals P, Tairou F, Van Allen M I et al.. Reduction in neural-tube defects after folic acid fortification in Canada.  N Engl J Med. 2007;  357 (2) 135-142
• 9 Meador K J, Baker G A, Browning N NEAD Study Group et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.  N Engl J Med. 2009;  360 (16) 1597-1605
• 10 Pennell P B, Peng L, Newport D J et al.. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.  Neurology. 2008;  70 (22 Pt 2) 2130-2136
• 11 EURAP Study Group . Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.  Neurology. 2006;  66 (3) 354-360
• 12 Meador K J, Baker G A, Browning N NEAD Study Group et al. Effects of breastfeeding in children of women taking antiepileptic drugs.  Neurology. 2010;  75 (22) 1954-1960